| Drug Type Small molecule drug | 
| Synonyms Polmacoxib/Pregabalin, Pregabalin/Polmacoxib, CG 651 + [1] | 
| Action blockers, inhibitors | 
| Mechanism CACNA2D1 blockers(Voltage-gated calcium channel alpha2/delta subunit 1 blockers), CACNA2D2 blockers(Voltage-gated calcium channel alpha2/delta subunit 2 blockers), COX-2 inhibitors(Cyclooxygenase-2 inhibitors) | 
| Therapeutic Areas- | 
| Active Indication- | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization- | 
| Inactive Organization | 
| License Organization- | 
| Drug Highest PhasePendingPhase 1 | 
| First Approval Date- | 
| Regulation- | 
| Molecular FormulaC8H17NO2 | 
| InChIKeyAYXYPKUFHZROOJ-ZETCQYMHSA-N | 
| CAS Registry148553-50-8 | 





